These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 15946912)

  • 21. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy.
    Orisio S
    J Nephrol; 1999; 12(1):9-17. PubMed ID: 10202997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-angiotensin system polymorphisms and renal graft function in renal transplant recipients.
    Argani H; Noroozianavval M; Aghaeishahsavari M; Veisi P; Rashtchizadeh N; Ghorbanihaghjo A; Bonyadi M; Asgarzadeh M; Hamzeiy H
    Saudi Med J; 2007 Oct; 28(10):1496-502. PubMed ID: 17914507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients.
    Slowinski T; Diehr P; Kleemann P; Fritsche L; Renders L; Budde K; Hauser IA; Neumayer HH; Hocher B
    Nephrol Dial Transplant; 2004 Nov; 19(11):2846-51. PubMed ID: 15353577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
    DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
    Pedersen-Bjergaard U; Dhamrait SS; Sethi AA; Frandsen E; Nordestgaard BG; Montgomery HE; Pramming S; Hougaard P; Thorsteinsson B
    Am J Med; 2008 Mar; 121(3):246.e1-8. PubMed ID: 18328310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics.
    Bautista LE; Vargas CI; Oróstegui M; Gamarra G
    Hypertens Res; 2008 Mar; 31(3):401-8. PubMed ID: 18497458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin-angiotensin-system gene polymorphisms and depression.
    Saab YB; Gard PR; Yeoman MS; Mfarrej B; El-Moalem H; Ingram MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1113-8. PubMed ID: 17499413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
    Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
    Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: role of ACE D/-240T haplotype.
    Fatini C; Sticchi E; Sofi F; Said AA; Pratesi G; Pulli R; Pratesi C; Abbate R
    J Vasc Surg; 2009 Dec; 50(6):1399-404. PubMed ID: 19782519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis.
    Xi B; Zeng T; Liu L; Liang Y; Liu W; Hu Y; Li J
    Breast Cancer Res Treat; 2011 Nov; 130(2):561-8. PubMed ID: 21638051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
    Jacobsen PK
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin gene polymorphisms in relation to severe chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Atilla G; Köse T; Baylas H; Berdeli A
    J Clin Periodontol; 2009 Mar; 36(3):204-11. PubMed ID: 19236533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis.
    Buraczyńska M; Grzebalska A; Spasiewicz D; Orłowska G; Ksiazek A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):330-6. PubMed ID: 12898858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
    Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
    Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Cetinkalp S; Erdogan M; Kosova B; Karadeniz M; Kutukculer A; Gunduz C; Tetik A; Topcuoglu N; Ozgen AG; Tuzun M
    J Diabetes Complications; 2008; 22(3):186-90. PubMed ID: 18413162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Fang W; Oreopoulos DG; Bargman JM
    Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.